A proof-of-concept clinical trial has been completed.
IHL-42X reduced AHI relative to baseline and improved patient reported sleep quality.
IHL-42X was well tolerated.
Low dose IHL-42X had the greatest reduction in AHI, 50.7% relative to baseline, and the THC levels were within legal limits for driving the morning after dosing.
What's not to like here........seems like onwards and upwards to me. Don't get your product knowledge mixed up with geographic uncertainties........just saying
IHL Price at posting:
15.5¢ Sentiment: Buy Disclosure: Held
